SPY376.70-4.72 -1.24%
DIA309.58-3.41 -1.09%
IXIC12,723.47-274.28 -2.11%

BRIEF-Regeneron Reports Q4 Non-GAAP Earnings Per Share Of $9.53

· 02/05/2021 06:42
BRIEF-Regeneron Reports Q4 Non-GAAP Earnings Per Share Of $9.53

- Regeneron Pharmaceuticals Inc REGN.O:

  • REGENERON REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL AND OPERATING RESULTS

  • Q4 NON-GAAP EARNINGS PER SHARE $9.53

  • Q4 GAAP EARNINGS PER SHARE $10.24

  • Q4 EARNINGS PER SHARE ESTIMATE $8.43 -- REFINITIV IBES DATA

  • Q4 2020 REVENUES INCREASED 30% TO $2.42 BILLION VERSUS Q4 2019

  • Q4 2020 EYLEA U.S. NET SALES INCREASED 10% TO $1.34 BILLION VERSUS Q4 2019

  • IN 2021, IN ADDITION TO ONGOING WORK ON COVID-19, WE EXPECT DIVERSIFIED GROWTH DRIVEN BY CONTINUED EYLEA MOMENTUM

  • REGENERON PHARMACEUTICALS - ANTICIPATE U.S. REGULATORY ACTION FOR LIBTAYO IN BOTH NON-SMALL CELL LUNG CANCER & BASAL CELL CARCINOMA WITHIN NEXT MONTH

  • NET PRODUCT SALES OF REGEN-COV WERE $146 MILLION IN Q4 OF 2020

  • SEES FY GAAP RESEARCH AND DEVELOPMENT $3,000 MILLION TO $3,175 MILLION

  • REGENERON PHARMACEUTICALS - IN JAN 2021, BOARD AUTHORIZED A NEW SHARE REPURCHASE PROGRAM TO REPURCHASE UP TO $1.5 BILLION OF CO'S COMMON STOCK

  • Q4 REVENUE VIEW $2.42 BILLION -- REFINITIV IBES DATA

Source text for Eikon: ID:nPn8r2BGpa

Further company coverage: REGN.O


((Reuters.Briefs@thomsonreuters.com;))